. 2022 Feb 21;13:784512. doi: 10.3389/fpsyg.2022.784512

TABLE 1.

Descriptive characteristics and symptoms across diagnostic group at treatment intake.

		AN		BN		BED		OSFED
	N	M	SD	M	SD	M	SD	M	SD	F	p	η ²
Age	292	28.70^a	10.82	30.73^b	11.88	39.95^a,b,c	12.71	29.26^c	11.90	10.05	< 0.001	0.094
BMI	282	17.91^a	2.36	29.66^a	22.38	38.75^a	10.55	23.46^a	6.18	27.22	< 0.001	0.225
Age at first ED	291	18.58	7.01	16.85	5.36	21.67	12.07	19.08	7.55	3.67	0.013	0.036
EDE-Q global	172	4.45^b	0.16	4.60^a	0.15	3.42^a,b	0.28	4.09^a	0.13	5.17	0.002	0.085
EDE-Q restraint	172	3.84^a	0.24	3.90^b	0.22	2.20^a,b,c	0.41	3.57^c	0.19	4.85	0.003	0.080
EDE-Q eating	172	3.78	0.20	4.20^a	0.19	3.19^a	0.35	3.27^a	0.16	5.56	0.001	0.090
EDE-Q shape	172	5.35	0.16	5.32	0.15	4.80	0.28	5.02	0.13	1.83	0.143	0.032
EDE-Q weight	172	4.82	0.19	4.96	0.17	3.89	0.33	4.53	0.15	3.38	0.020	0.057
CIA	171	39.05	1.46	38.61	1.32	32.21	2.50	35.29	1.15	3.11	0.028	0.053
BDI	170	19.78	1.98	24.53	1.77	25.83	3.35	21.18	1.54	1.61	0.188	0.028
RSES	171	9.78	0.87	9.60	0.79	12.33	1.48	10.51	0.68	1.03	0.380	0.018

Bolded text indicates test significant at p < 0.01. Superscripts indicate significant post-hoc comparisons. AN, Anorexia Nervosa; BN, Bulimia Nervosa; BED, Binge Eating Disorder; OSFED, Other Specified Feeding or Eating Disorder; BMI, Body Mass Index; EDE-Q, Eating Disorder Examination Questionnaire; CIA, Clinical Impairment Assessment; BDI, Beck Depression Inventory; RSES, Rosenberg Self-Esteem Scale.